FY 2022 Final Results
RUA Life Sciences’ FY 2022 results included total revenues that increased by 6% on the previous...
Read moreA year of strategic focus
2021 proved to be an eventful year for MCH. The new Board sought to re-engineer the Group into a...
Read moreFY22 first half trading update: supply chain pressure
In a trading update for the half year to 30 June 2022, Mpac reports that supply chain difficulties...
Read moreFactory extension open to satisfy demand
A site visit to Burton-on-Trent for the official opening of the new manufacturing facility proved...
Read moreNo material outflows but markets impact AUM
On 30 June 2022 (end-Q3 of Impax’s FY22), AUM totalled £34.5bn, 9% down on the end-Q2 AUM of...
Read moreCollaboration to develop poultry red mite vaccine
ECO Animal Health has established a research collaboration with Moredun Research Institute aimed at...
Read moreFY22 results in line: FY23 emphasis on Vaping
For the year to 31 March 2022, Supreme PLC reported revenue of £130.8m, +7.0%YoY, gross profit of...
Read moreA useful addition to XF-73’s profile
Destiny have announced a new XF-73 research programme on the prevention of oral mucositis (OM) in...
Read moreStrong growth, surging profits and maiden dividend
LendInvest's first full year results as a publicly quoted company have not disappointed: it...
Read more